A 52-WEEK PHASE 3 CLINICAL TRIAL OF RESMETIROM IN 180 PATIENTS WITH WELL-COMPENSATED NASH CIRRHOSIS

被引：0
|
作者：
Harrison, Stephen A. [1 ]
Alkhouri, Naim [2 ]
Taub, Rebecca A. [3 ]
Neff, Guy W. [4 ]
Kowdley, Kris V. [5 ]
Noureddin, Mazen [6 ]
机构：
[1] Univ Oxford, Pinaacle Res Ctr, Oxford, England
[2] Arizona Liver Hlth, Chandler, AZ USA
[3] Madrigal Pharmaceut, Conshohocken, PA USA
[4] Covenant Metab Specialists LLC, Sarasota, FL USA
[5] Liver Care Network, Seattle, WA USA
[6] Houston Methodist Hosp, Houston, TX USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
100
引用
收藏
页码：S90 / S92
页数：3
相关论文
共 50 条
  • [1] BASELINE CHARACTERISTICS IN WELL-COMPENSATED NASH CIRRHOSIS PATIENTS DIAGNOSED WITH OR WITHOUT A LIVER BIOPSY IN MAESTRO-NASH-OUTCOMES, A CLINICAL OUTCOME PHASE 3 STUDY ASSESSING THE EFFECT OF RESMETIROM IN WELL COMPENSATED NASH CIRRHOSIS
    Bansal, Meena
    Schattenberg, Joern
    Kowdley, Kris
    Noureddin, Mazen
    Loomba, Rohit
    Taub, Rebecca
    Labriola, Dominic
    Schneider, David
    HEPATOLOGY, 2024, 80 : S645 - S647
  • [2] RESMETIROM IMPROVES THE ATHEROGENIC LIPID/LIPOPROTEIN PROFILE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRO-NASH TRIAL
    Alkhouri, Naim
    Bedossa, Pierre
    Guy, Cynthia D.
    Schattenberg, Joern M.
    Loomba, Rohit
    Taub, Rebecca A.
    Labriola, Dominic
    Moussa, Sam
    Neff, Guy W.
    Sanyal, Arun
    Noureddin, Mazen
    Bansal, Meena B.
    Ratziu, Vlad
    Harrison, Stephen A.
    HEPATOLOGY, 2023, 78 : S1207 - S1213
  • [3] Reduction in Fibrosis and Steatohepatitis Imaging and Biomarkers in a Phase 3 52 Week Resmetirom NASH Trial
    Harrison, Stephen
    Alkhouri, Naim
    Taub, Rebecca
    Neff, Guy
    Baum, Seth J.
    Younes, Ziad H.
    Bashir, Mustafa
    JOURNAL OF HEPATOLOGY, 2021, 75 : S200 - S200
  • [4] ENHANCED LIVER FIBROSIS (ELF) SCORE SIGNIFICANTLY PREDICTS 52-WEEK LIVER DECOMPENSATION IN PATIENTS WITH COMPENSATED NASH CIRRHOSIS
    Vilar-Gomez, Eduardo, II
    Noureddin, Mazen
    Harrison, Stephen A.
    Vuppalanchi, Raj
    Allgood, Adam
    Shlevin, Harold
    Chalasani, Naga P.
    HEPATOLOGY, 2019, 70 : 728A - 729A
  • [5] Biomarkers, imaging and safety in a well-compensated NASH cirrhotic cohort treated with resmetirom, a thyroid hormone receptor beta agonist, for 52 weeks
    Harrison, Stephen
    Kowdley, Kris
    Taub, Rebecca
    Alkhouri, Naim
    Neff, Guy
    JOURNAL OF HEPATOLOGY, 2022, 77 : S87 - S87
  • [6] RESMETIROM TREATMENT HELPS RESTORE THYROID HORMONE LEVELS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRONASH TRIAL
    Harrison, Stephen A.
    Bedossa, Pierre
    Guy, Cynthia D.
    Schattenberg, Joern M.
    Loomba, Rohit
    Taub, Rebecca A.
    Labriola, Dominic
    Moussa, Sam
    Neff, Guy W.
    Sanyal, Arun
    Noureddin, Mazen
    Bansal, Meena B.
    Alkhouri, Naim
    Ratziu, Vlad
    HEPATOLOGY, 2023, 78 : S1213 - S1219
  • [7] Artificial intelligence to measure fibrosis change on liver biopsy in MAESTRO-NASH a phase 3 52-week serial liver biopsy study in 966 patients with NASH treated with resmetirom or placebo
    Harrison, Stephen
    Taub, Rebecca
    Labriola, Dominic
    Ren, Yayun
    Chng, Elaine
    Tai, Dean
    JOURNAL OF HEPATOLOGY, 2023, 78 : S112 - S112
  • [8] THE EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 52-WEEK DATA FROM A PHASE 3 CLINICAL TRIAL
    De Benedetti, Fabrizio
    Brunner, Hermine
    Allen, Roger
    Brown, Diane
    Chaitow, Jeffrey
    Pardeo, Manuela
    Espada, Graciela
    Flato, Berit
    Horneff, Gerd
    Devlin, Clare
    Kenwright, Andrew
    Schneider, Rayfel
    Woo, Patricia
    Martini, Alberto
    Lovell, Daniel
    Ruperto, Nicola
    RHEUMATOLOGY, 2012, 51 : 76 - 76
  • [9] Intervention with oral LPCN 1148 improves sarcopenia and hepatic encephalopathy (HE) in patients with cirrhosis: a 52-week phase 2 randomized clinical trial
    Bruno, Benjamin
    Weavil, Josh
    Ogle, Jonathan
    Chidambaram, Nachaippan
    Carey, Elizabeth
    Danford, Christopher
    Fricker, Zachary
    Galati, Joseph
    Lee, William M.
    Mantry, Parvez
    Shetty, Kirti
    DelConte, Anthony
    Patel, Mahesh
    Sanyal, Arun J.
    Lai, Jennifer
    JOURNAL OF HEPATOLOGY, 2024, 80 : S10 - S11
  • [10] Primary results from MAESTRO-NASH a pivotal phase 3 52-week serial liver biopsy study in 966 patients with NASH and fibrosis
    Harrison, Stephen
    Bedossa, Pierre
    Guy, Cynthia
    Schattenberg, Jorn
    Loomba, Rohit
    Taub, Rebecca
    Labriola, Dominic
    Moussa, Sam
    Neff, Guy
    Sanyal, Arun
    Noureddin, Mazen
    Bansal, Meena
    Alkhouri, Naim
    Ratziu, Vlad
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1 - S1
12345